Posts Tagged: medicine
Farm workers with masks pick strawberries near Carlsbad, San Diego County. (Photo: Simone Hogan, via Shutterstock)
Back in April, when the lockdown was first beginning, a California Farm Bureau study reported that the agriculture sector had lost more than 2.4 million jobs directly attributable to the COVID-19 pandemic. Now, along with the financial hit, farm workers are suffering through increased risk of deadly infection.
An eye chart seen through a pair of glasses. (Photo: Coprid, via Shutterstock)
OPINION: With all that we do to try to help our children succeed at school, we are failing to properly screen students for correctable vision problems that can hinder learning.
A high-resolution image of human egg cells. (Jezper, via Shutterstock)
The president of the California stem cell agency, Randy Mills, yesterday said that the firms that responded to an ambitious proposal to create a $150 million public/private partnership were seeking to make a “better deal” than the agency had offered. Mills said that the agency was “not going to give away something that is not in the best interests of the people of California.”
A liquid nitrogen bank containing a suspension of stem cells. (Photo: Elena Pavlovich)
If you are interested in how the state of California is going to spend its final $800 million or so on stem cell research, you should catch a key meeting next Tuesday in Oakland, which also can be heard online. The session involves the 29-member, governing board of the $3 billion California Institute for Regenerative Medicine (CIRM), as the state stem cell agency is formally known.
A depiction of human genetics. (Image: Crystal Image Photo, via Shutterstock)
California’s stem cell agency has embarked on what is likely to be an exhaustive review of genetic alteration of human embryos with likely recommendations for changes in the $3 billion research effort. The 11-year-old agency plans to examine a host of issues ranging from inadvertent, inheritable changes in the human race to informed consent on the part of patients.
A digital illustration of DNA structure. (Image by Matha Graphics, via Shutterstock)
The $3 billion California stem cell agency next Thursday will convene a day-long examination of human gene editing, a field that could be a “gold mine for biotechnology” and perhaps alter the human race permanently. “Easy DNA Editing Will Remake the World. Buckle Up.” is the way Wired magazine put it in a headline on a lengthy overview article last July.
A simulated view through a microscope of bacterias in the shape of California. (Illustration: Pat Bengtsson, via Shutterstock)
With no fanfare, California’s $3 billion stem cell agency is making a significant step forward in openness and transparency regarding the dealings of its governing board, which operates outside of the control of the governor and Legislature. Tuesday’s meeting of the directors’ Science Subcommittee will be available live for the first time — for all practical purposes — on the Internet and as an audiocast, including access to presentations that are used at the meeting.
Pharmaceuticals and money -- elements in the debate over a cost-disclosure bill. (Photo: O.S. Fisher, Shutterstock)
An attempt to force drug makers to disclose their costs and profits for drugs that sell wholesale for more than $10,000 annually was derailed in the Legislature, facing strong opposition from an industry targeting similar measures in other states. The forces battling over the bill include some of the most powerful in California.
Close to 1.2 million adults in California live with serious mental illnesses. Each one of these cases is an individual—a parent or sibling or child—and no two people battling the same condition respond to the same treatment alike. Treating mental conditions—and in fact, treating all illnesses—has to be based on the fact that every person is unique and each patient requires therapies that suit him or her best.
OPINION: Occasionally, a patient can find the information on the individual insurer website, but the formularies are displayed differently with each plan, making it difficult to compare plans to each other. In addition, there is no way to compare out-of-pocket costs.